International Initiatives on the Assessments of the Value of Medical Technologies

Leadership Group:

Mirella Marlow, MBA, MA, Programme Director, Devices and Diagnostic Systems, Centre for Health Technology Evaluation, The National Institute for Health and Care Excellence (NICE), London, England, United Kingdom

Karolina Socha-Dietrich, Organization for Economic Cooperation and Development (OECD), Copenhagen, Denmark

Adriana Velazquez Berumen, MSc, Senior Advisor and Focal Point on Medical Devices, World Health Organization (WHO), Geneva, Switzerland

Yves Verboven, Director, Market Access & Economic Policies MedTech Europe, Brussels, Belgium

Øyvind Melien, MD, PhD, MSc, Specialist in Clinical Pharmacology and Chair of Secretariat for the Norwegian National System for Managed Introduction of Health Technologies within the Specialist Health Services. Dept. of Medical Devices and Medicinal Products Norwegian Directorate of Health, Oslo, Norway

Claudia Wild, PhD, Director, Ludwig Boltzman Institute for Health Technology Assessment (LBI-HTA), and EUnetHTA, Austria

Reinhard Busse, MPH, University of Berlin, MEDTecHTA, Germany

Giuditta Callea, PhD, University of Bocconi, MedTecHTA, Italy

Jing Xie, PhD, Vice President, Clinical Affairs, Medical Device Innovation Consortium (MDIC), USA

Ralph Ives, Executive Vice President of Global Strategy and Analysis, AdvaMed, USA

Edward L. Trimble, MD, MPH, Director, Center for Global Health, National Cancer Institute, National Institute of Health, USA

Paul C. Pearlman, PhD, Science Policy Advisor/Program Officer, Center for Global Health, National Institutes of Health, National Cancer Institute, USA

TBD, Representatives from Asia-Pacific and Latin America

Objective:

Provide global harmonization and consistency in utilizing and adapting health technology assessment as a supportive tool to inform decisions in the lifecycle of medical technologies to the benefit of the patients, health systems, and society including the value of other tools and initiatives on novel value frameworks to inform decisions and meet the policy objectives.

If you are interested in joining this ISPOR HTA Council Working Group Review Group, please complete the ISPOR Scientific and Health Policy Working Groups Form.

ISPOR HTA Council Home